This year’s 2015 World Orphan Drug Congress is expected to have over 450 more attendees than last year. Stakeholders and influences in the orphan drug and rare disease sector will meet to discuss how they can best push forward with strategy, advocacy and partnering within the rare disease space.

The agenda for the conference’s 6th year will cover everything from pricing and reimbursement, commercialization and improving on collaborations.

Attendees can expect to:

  • Discuss pressing issues such as the pricing and reimbursement debate, commercialisation challenges and engaging with patients during research and development of new therapies.
  • Meet and interact with representatives from pharma, biotechs, payers, government, regulators, academia and patient groups.
  • Use extended networking time to seek out and build partnerships to speed up the development of orphan drugs.

 

Check out Terrapinn’s brochure on the event.

The event will take place at the Geneva Hotel and Conference Center in Geneva on the 12th and 13th of November, 2015.

For standard attendance you must register before June 12th.

X